Navigation Links
140-Fold Increase of Protein Achieved in Pichia Fermentation


NBS microbiologists recently assisted researchers at the University of California in achieving a 140-fold increase in protein production from a recombinant strain of Pichia pastoris yeast. Top yields by the researchers thus far had been 1.4 mg/L of a throm-bomodulin fragment when culturing Pichia in shake flasks. By switching to a BioFlo 3000 fermentor, NBS scientists were able to overcome the two main problems which plagued earlier studies insufficient oxygen, and a temperature increase of as much as 25C generated by the organisms prolific growth. Although fermentors commonly achieve yields of ten or more times that of shakers, these extraordinary results were largely due to the unique capabilities inherent in the BioFlo 3000 fermentor.


An Ideal Pichia Culturing System
The versatile BioFlo 3000 batch, fed-batch and continuous fermentor offers several design advantages. Uniquely, this fermentor comes with a built-in two gas controller for optimizing dissolved oxygen (DO) during fermentation, (as well as a four-gas controller for use during cell culture). Using any of the systems four operating modes, agitation may be increased and/or pure oxygen added throughout the run to maintain the desired DO level.

Second, the vessels stainless-steel water-jacket provides superior heat induction capability. A PID controller regulates culture temperature for optimum protein production in this case at 30C.

In addition, five pumps provide programmable addition and harvesting functions, which ensured tight control over methanol, antifoam and nutrient addition in these studies. Furthermore, BioCommand, NBS proprietary Windows-based software can be used to automate process control, log and graph data on-line, or optimize product yields. NBS will even supply software control algorithms and protocols expressly written for Pichia pastoris to BioFlo 3000 users upon request.


Materials & Methods
In these studies, a Muts strain of Pichia was grown in fed-batch and continuous culture. AFS BioCommand helped to control and later optimize nutrient feeding and oxygen supplementation. Production of the thrombomodulin fragment in the fed-batch studies reached an average of 200 mg/L, a 142-fold increase over shake flasks. In the final study, a continuous culture process utilizing an on-line separation system to harvest products and recycle the cells enabled an extended production phase, resulting in yields four to five times that of the fed batch cultures.


About Pichia
Pichia pastoris (current name Komagataella pastoris) has been touted as an exciting new expression system, and an excellent alternative to E. coli , because the proteins produced are glycolated, typically folded correctly and secreted directly into the culture medium. For article reprints or product literature contact your NBS sales representative. To discuss contract process development, contact Dr. Julia Cino, at our Edison, NJ headquarters at 800-631-5417 or write to us at bioinfo@nbsc.com.


Caption:
With a built-in gas controller for regulating oxygen supplementation, the BioFlo 3000 readily meets the high-oxygen demands of Pichia pastoris yeast. This PC-compatible fermentor includes sensors, pumps, interchangeable vessels and impellers to adapt to the needs of virtually any animal, insect, microbial or plant cell line.



'"/>

Source:


Page: All 1 2

Related biology technology :

1. Increase the Power and Sensitivity for Your cDNA Synthesis with the New Transcriptor Reverse Transcriptase
2. Increased Sensitivity in Microarray Analysis
3. Increase Protein Activity and Yield
4. Increased Transfer Efficiency Using a Discontinuous Buffer System With the Trans-Blot SD Cell
5. Increase Your Organizations Productivity with LabVIEW
6. Increased Analyte Sensitivity through the Utility of Enhanced Mass-Resolution on the FinniganTSQ Quantum Discovery
7. A New C-Terminal GST Vector for Protein Production in S. pombe
8. New Mammalian Two-Hybrid System Detects Protein-Protein Interactions
9. Antibodies for Studying NMDA Receptor Protein Expression and Synapse-Specific Immunolabeling
10. Simple, Sensitive, and Rapid Detection of FLAG -Tagged Fusion Proteins
11. New Yeast Cloning System for Producing Proteins with Native Amino Acid Sequences
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/24/2017)... KONG, Feb. 24, 2017 China Cord Blood Corporation ... China,s leading provider of cord blood collection, laboratory testing, ... today announced its unaudited financial results for the third ... ended December 31, 2016. Third Quarter of ... third quarter of fiscal 2017 increased by 18.6% to ...
(Date:2/23/2017)... and NEW YORK ... HIMSS, Lumeon , a leading digital health ... Telehealth), a provider of telemedicine and remote patient ... pathways for telemedicine reimbursements.  DN ... their patients, in real-time, extending consultations beyond a ...
(Date:2/23/2017)... 23, 2017  In Atlanta, it seems everyone has a ... intertwine to create an expressive and dynamic community unlike any ... and contribute to it. With their newest ... seeks to carry on that tradition with a unique, ... salon is the newest of 13 nationwide locations, ...
(Date:2/23/2017)... ... 2017 , ... David Nolte, PhD accepted Purdue University’s 2016 ... Research Park of West Lafayette, Indiana. , The top commercialization award is ... success with, commercializing discoveries from Purdue research. “This award is truly an honor. ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 7, 2017 The biometrics ... by the confluence of organizations, desires to better ... knowledge-based systems (password and challenge questions), biometrics is ... government systems. The market is driven by use ... between consumer and enterprise uses cases, with consumer-facing ...
(Date:2/7/2017)... BEACH, New York , February 7, 2017 /PRNewswire/ ... known as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" ... identity management and electronic transaction processing services, is pleased ... reorganization of the Company. Effective January 31, ... of the Board of Directors, CEO and President.  An ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
Breaking Biology News(10 mins):